文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

诺如病毒传播与疫苗接种的数学模型研究

Modelling norovirus transmission and vaccination.
PubMed 文献 · Vaccine · 2018-07-31

该研究建立年龄别动态数学模型,利用德国年龄分层法定报告数据,采用自报告马尔可夫模型校正报告变异,并用序贯蒙特卡洛粒子滤波估计参数。模型显示常规免疫可使诺如病毒发病率最多降低70.5%,不同目标年龄组的策略效率因结局而异,且对疫苗作用模式假设敏感。作者认为疫苗接种可能是有效策略,但需进一步确定疫苗效力、作用模式及成本效果。

要点

  • 常规免疫可使诺如病毒发病率最多降低70.5%,即使疫苗不能提供完全保护。
  • 针对婴幼儿的策略在预防感染上更高效,针对老年人的策略在预防严重结局上更优。
  • 不同策略的相对效率取决于所考虑的结局,且对疫苗作用模式假设敏感。

核心结论

  • 模型提供了人群水平诺如病毒动态传播模型的稳健估计。
  • 疫苗接种可能是预防诺如病毒感染的有效策略,但需进一步研究确定疫苗效力、作用模式及免疫成本效果。

研究设计与样本

  • 研究建立年龄别动态数学模型模拟诺如病毒传播与疫苗接种,数据主要来自年龄分层的法定报告病例时间序列。
  • 采用自报告马尔可夫模型校正德国诺如病毒法定报告随年龄和时间的变异,并使用序贯蒙特卡洛粒子滤波估计模型参数。
  • 将估计模型扩展应用于评估多种免疫策略的潜在影响,并对疫苗作用模式及其他疫苗相关参数进行敏感性分析。

主要发现

  • 常规免疫可使诺如病毒发病率最多降低70.5%,即使疫苗不能提供完全保护。
  • 针对婴幼儿和幼儿的策略在预防感染方面更高效,而针对老年人的策略在预防严重结局方面更优。
  • 不同目标年龄组替代策略的相对效率取决于所考虑的结局,且对疫苗作用模式假设敏感。

临床怎么用

  • 作者认为疫苗接种可能是预防诺如病毒感染的有效策略。
  • 作者指出需进一步研究确定诺如病毒疫苗效力、作用模式及免疫成本效果。

局限性

  • 诺如病毒疾病存在漏报,人群水平传播动态仍知之甚少。
  • 疫苗效力、作用模式及免疫成本效果尚需进一步研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Norovirus is thought to be responsible for a fifth of all acute gastroenteritis cases globally each year. The population level transmission dynamics of this very common virus are still poorly understood, in part because illness is under-reported. With vaccines undergoing clinical trials, there is a growing need for appropriate, empirically grounded models, to predict the likely impact of vaccination. METHODS: We developed a dynamic age-specific mathematical model of norovirus transmission and vaccination, informed by available data, particularly age-stratified time series case notification data. We introduce the use of a self-reporting Markov model to account for variation by age and over time in the statutory reporting of norovirus in Germany. We estimated the model using a sequential Monte Carlo particle filter. We then extended and applied our estimated model to investigate the potential impact of a range of immunisation strategies. We performed sensitivity analyses on the mode of vaccine action and other vaccine-related parameters. RESULTS: We find that routine immunisation could reduce the incidence of norovirus by up to 70.5% even when those vaccines do not provide complete protection from disease. Furthermore, we find that the relative efficiency of alternative strategies targeting different age groups are dependant on the outcome we consider and are sensitive to assumptions on the mode of vaccine action. Strategies that target infants and toddler are more efficient in preventing infection but targeting older adults is preferable for preventing severe outcomes. CONCLUSIONS: Our model provides a robust estimate of a dynamic transmission model for norovirus at the population level. Vaccination may be an effective strategy in preventing disease but further work is required to ascertain norovirus vaccine efficacy, its mode of action and to estimate the cost-effectiveness of immunisation against norovirus.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gaythorpe KAM, Trotter CL, Conlan AJK, et al. Modelling norovirus transmission and vaccination. Vaccine. 2018. PMID: 30076105. doi:10.1016/j.vaccine.2018.07.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。